Dry eye. other disorders of lacrimal gland
Conditions
Interventions
Intervention 1: Omega-3 Capsule b.i.d. for one month. Intervention 2: Placebo gelatinous capsule b.i.d for one month.
Treatment - Drugs
Placebo
Omega-3 Capsule b.i.d. for one month
Placebo gelatinous capsule b.i.d for one month
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Subjects with Tear Break up time of less than 10 seconds Exclusion Criteria: The subjects with blood coagulation problems and those who take blood thinning medications such as warfarin or Coumadin, subject with the history of stomach ulcer, hemorrhage, or surgery in the past three months, history of allergies to fish oil or gelatinous capsules.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tear Break Up time. Timepoint: Before and after one month intervention. Method of measurement: The time that takes for the first dry spot to appear following blinking after fluorescin instillation.;Tear secretion. Timepoint: Before and after intervention. Method of measurement: Schirmer test- Wetting of the filter paper after 5 minutes.;Foreign body sensation, photophobia, blur vision, Burning. Timepoint: Before and after intervention. Method of measurement: Filling OSDI questionnaire. | — |
Countries
Albania, Iran (Islamic Republic of)
Contacts
Public ContactDr. Haleh Kangari
Shahid Beheshti University of Medical Sciences, Faculty of Rehabilitation, Optometry Department
Outcome results
None listed